April 20, 2016
AV Medical Completes Study of Chameleon Angioplasty Balloon Catheter
April 21, 2016—AV Medical Technologies Ltd. announced the completion of a 30-patient study that evaluated the company’s Chameleon angioplasty balloon catheter. The study was conducted by Anthony Verstandig, MD, Director of Interventional Radiology at Shaare Zedek Medical Center in Jerusalem, Israel. The study results were presented during an oral abstract presentation at SIR 2016, the Society for Interventional Radiology annual meeting held April 2–7 in Vancouver, British Columbia.
The company is anticipating a United States launch of the Chameleon device, which received US Food and Drug Administration clearance in October 2015.
Discussing his initial clinical experience with the Chameleon at SIR, Dr. Verstandig stated, “The Chameleon demonstrated clear advantages compared to standard balloon designs. Among these are reduced catheter exchanges and maintaining guidewire access during contrast injection through the catheter. In addition, the Chameleon design allows hands-free reflux angiography, simplifying visualization of the entire arteriovenous graft circuit.”
The Chameleon’s SuperVision proximal injection technology enables simultaneous catheter based interventions and contrast fluid injection for imaging in one device, eliminating multiple exchanges and maintaining guidewire access. The company’s technology enhances performance by achieving superior targeted imaging and a smoother, more efficient procedure, stated AV Medical.